Literature DB >> 18786078

Prevalence of cognitive impairment in patients attending pre-dialysis clinic.

Rebekah S Nulsen1, M Magdi Yaqoob, Althea Mahon, Meagan Stoby-Fields, Mike Kelly, Mira Varagunam.   

Abstract

Approximately 20-30% of patients on renal replacement therapy (RRT) have cognitive impairment. Less is known about the prevalence of cognitive impairment in patients with advanced kidney disease awaiting the initiation of dialysis. Routine cognitive assessment was implemented in the pre-dialysis clinic, which enabled the Nephrologist and Pre-dialysis Nurse to identify those patients with impaired cognitive function and utilise this information to assess the suitability for self-care treatments, such as peritoneal dialysis, as well as to adapt information to meet their needs. Subsequently, a cross-sectional single-centre audit was undertaken to identify the prevalence of cognitive impairment in 132 consecutive new referrals to the pre-dialysis clinic using the Mini-mental State Examination (MMSE). Twenty percent (95% CI = 0.13, 0.27) were classified as cognitively impaired. Those with cognitive impairment were significantly older, and had lower eGFR and higher serum creatinine. It can be concluded that approximately 1 in 5 patients attending the pre-dialysis clinic has cognitive impairment, which may not be apparent on a routine clinical history. Cognitive function assessment is recommended for all, but particularly to the older patient, before advising on choice of dialysis modality or opting for conservative treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786078     DOI: 10.1111/j.1755-6686.2008.00028.x

Source DB:  PubMed          Journal:  J Ren Care        ISSN: 1755-6678


  9 in total

Review 1.  Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care.

Authors:  Dirk M Hermann; Andreas Kribben; Heike Bruck
Journal:  J Neural Transm (Vienna)       Date:  2014-01-23       Impact factor: 3.575

2.  A Qualitative Assessment of Mismatch Between Dialysis Modality Selection and Initiation.

Authors:  Susan Ziolkowski; Scott Liebman
Journal:  Perit Dial Int       Date:  2016 Jul-Aug       Impact factor: 1.756

3.  Patient perspectives on informed decision-making surrounding dialysis initiation.

Authors:  Mi-Kyung Song; Feng-Chang Lin; Constance A Gilet; Robert M Arnold; Jessica C Bridgman; Sandra E Ward
Journal:  Nephrol Dial Transplant       Date:  2013-07-30       Impact factor: 5.992

4.  Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.

Authors:  Christopher B Brady; J Michael Gaziano; Roberta A Cxypoliski; Peter D Guarino; James S Kaufman; Stuart R Warren; Pamela Hartigan; David S Goldfarb; Rex L Jamison
Journal:  Am J Kidney Dis       Date:  2009-07-23       Impact factor: 8.860

5.  High burden and unmet patient needs in chronic kidney disease.

Authors:  Leeann Braun; Vipan Sood; Susan Hogue; Bonnie Lieberman; Catherine Copley-Merriman
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-12-13

6.  Cognitive Performance Is Highly Stable over a 2-Year-Follow-Up in Chronic Kidney Disease Patients in a Dedicated Medical Environment.

Authors:  Janine Gronewold; Olga Todica; Ulla K Seidel; Michaela Volsek; Andreas Kribben; Heike Bruck; Dirk M Hermann
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

7.  Decision-making for people with dementia and advanced kidney disease: a secondary qualitative analysis of interviews from the Conservative Kidney Management Assessment of Practice Patterns Study.

Authors:  Jemima Scott; Amanda Owen-Smith; Sarah Tonkin-Crine; Hugh Rayner; Paul Roderick; Ikumi Okamoto; Geraldine Leydon; Fergus Caskey; Shona Methven
Journal:  BMJ Open       Date:  2018-11-12       Impact factor: 2.692

8.  Cognitive Impairment and Associated Factors Among Chronic Kidney Disease Patients: A Comparative Cross-Sectional Study.

Authors:  Yibeltal Yismaw Gela; Ayechew Adera Getu; Aynishet Adane; Bezawit Mulat Ayal; Yonas Akalu; Adugnaw Ambelu; Mengistie Diress; Yigizie Yeshaw
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-17       Impact factor: 2.570

9.  AST-120 Reduces Neuroinflammation Induced by Indoxyl Sulfate in Glial Cells.

Authors:  Simona Adesso; Irene Paterniti; Salvatore Cuzzocrea; Masaki Fujioka; Giuseppina Autore; Tim Magnus; Aldo Pinto; Stefania Marzocco
Journal:  J Clin Med       Date:  2018-10-17       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.